The 2015 All-Europe Research Team: Banks, No. 3: Huw van Steenis & team
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The 2015 All-Europe Research Team: Banks, No. 3: Huw van Steenis & team

2015-03-tom-johnson-all-europe-research-team-huw-van-steenis.jpg

Advancing from runner-up to claim the No. 3 spot on this list are Huw van Steenis and his Morgan Stanley squad, who win praise from investors for their comprehensive and thorough reporting.

< The 2015 All-Europe Research Team

2015-03-tom-johnson-all-europe-research-team-huw-van-steenis.jpg

Huw van Steenis & team

Morgan Stanley

First-place appearances: 5


Total appearances: 23


Team debut: 1989


Advancing from runner-up to claim the No. 3 spot on this list are Huw van Steenis and his Morgan Stanley squad, who win praise from investors for their comprehensive and thorough reporting. The researchers track 50 European banks and have assigned the sector an equal weight rating. “We see upside coming from unconventional European Central Bank policy; bank restructuring, in terms of selling some businesses and assets and reprioritizing others; and switching on dividends for some banks,” explains van Steenis, 45. However, “concerns of litigation, regulatory ratchet and a weak macro hold us back from the overall sector.” Their favorite name going forward is Swiss financial services giant UBS, which “will rerate in 2015, as the market will reward portfolio restructuring, extra cost discipline and faster noncore runoff,” he says. The market is worried about the cost of lawsuits the bank is facing, as well as “ratcheting regulations’ pinching dividend paying capacity,” van Steenis acknowledges, “but we hope in 2015 UBS will be over the worst of litigation and new standards will be known potentially as early as February, helping to lift the fog for investors.” UBS’s shares ended January at Sf15.25, and his crew projects a rise to Sf22.



Gift this article